Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00672503 · ClinicalTrials.gov registry record
Decreasing Catheter-Associated Urinary Tract Infections in the Pediatric Intensive Care Unit
A clinical trial, sponsored by Children's Mercy Hospital Kansas City.
- Completed
- Registry status
- 321
- Enrollment target
NCT00672503: Completed study, sponsored by Children's Mercy Hospital Kansas City.
NCT00672503 is a clinical trial that has completed, run by Children's Mercy Hospital Kansas City. The registered enrollment target is 321 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00672503 has completed, sponsored by Children's Mercy Hospital Kansas City.
- COMPLETED
- Registry status
- 321 participants
- Enrollment target
Study Summary
The purpose of this study is to identify risk factors associated with indwelling urinary catheters, as well as to assess the nurses' knowledge and adherence to hospital policies. The study will also include a very extensive literature search in an attempt to create a national standard or guideline.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 321 participants |
| Start Date | 2008-05 |
| Est. Completion | 2011-10 |
What the finished NCT00672503 record still lists
NCT00672503 is an observational study that tracks outcomes without assigning an intervention. The registered 321 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 0 interventions.
NCT00672503 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00672503 about?
NCT00672503 is a clinical study titled "Decreasing Catheter-Associated Urinary Tract Infections in the Pediatric Intensive Care Unit". The purpose of this study is to identify risk factors associated with indwelling urinary catheters, as well as to assess the nurses' knowledge and adherence to hospital policies. The study will also include a very extensive literature search in an attempt to create a national standard or guideline.
What is the current status of trial NCT00672503?
This trial is currently completed. The enrollment target is 321 participants. The study started on 2008-05. Estimated completion is 2011-10.
Who is sponsoring clinical trial NCT00672503?
This trial is sponsored by Children's Mercy Hospital Kansas City, which has 184 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03715933 · 321 participants · Phase 1
Phase 1 Study of INBRX-109 in Subjects With Locally Advanced or Metastatic Solid Tumors Including Sarcomas
- NCT05922878 · 321 participants · Phase 2
Study of ALTO-300 in MDD
- NCT04090359 · 322 participants · Phase 4
Dual Mobility Acetabular Cups in Revision TJA
- NCT04924075 · 322 participants · Phase 2
Belzutifan/MK-6482 for the Treatment of Advanced Pheochromocytoma/Paraganglioma (PPGL), Pancreatic Neuroendocrine Tumor (pNET), Von Hippel-Lindau (VHL) Disease-Associated Tumors, Advanced Gastrointestinal Stromal Tumor (wt GIST), or Solid Tumors With HIF-2α Related Genetic Alterations (MK-6482-015)
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia